Location: | London, Hybrid |
---|---|
Salary: | £45,700 to £55,240 per annum |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 5th March 2025 |
---|---|
Closes: | 9th March 2025 |
Job Ref: | MED05110 |
Location: South Kensington Campus - Hybrid
About the role
We are looking for a Clinical Trial Monitor to join our team.
The Imperial Clinical Trials Unit-Cancer (ICTU-Ca), led by Professor Michael Seckl through its close association with the Imperial Clinical Trials Unit and Imperial Experimental Cancer Medicine Centre, provides a core accredited environment to develop and conduct world-class cancer clinical trials led by Imperial College. With a major focus on precision medicine and proof of concept clinical trials, the ICTU-Ca currently undertakes studies in the phase Ib to phase III space across multiple sites of disease, at both National and International levels. The cancer trial portfolio exploits the research expertise in our Department to enable trials that include new and exciting imaging modalities, translational research initiatives and innovative study designs as they evolve.
ICTU-Ca forms part of the Imperial Clinical Trials Unit (ICTU). Cancer is just one of several therapeutic areas including cardiovascular and metabolic disease, respiratory, HIV / infectious diseases, surgery and emergency and critical care. These disciplines all come together under the overarching, UKCRC registered ICTU.
What you would be doing
What we are looking for
What we can offer you
Further information
This role is full-time and fixed term for 12 months in the first instance based at South Kensington Campus.
You will need to complete an online application.
Should you require any further details on the role please contact:
Mr Philip Badman – p.badman@imperial.ac.uk
Type / Role:
Subject Area(s):
Location(s):